Join to View Full Profile
5626 Oberlin DrSuite 110San Diego, CA 92121
Phone+1 858-952-1820
Dr. Datnow is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Brian Datnow, MD, is a San Diego-based pathologist specializing in anatomic and clinical pathology. He completed his residency at Brigham and Women's Hospital and graduated from the University of the Witwatersrand. Since 1998, he has been a Clinical Professor at the UC San Diego Health Physician Network. His experience includes oral pathology, and he has contributed to numerous publications, primarily focused on breast cancer, with a notable focus on the I-SPY2 clinical trial. His work has been widely cited, highlighting his involvement in assessing residual cancer burden and survival outcomes.
Education & Training
Mass General Brigham/Brigham and Women's HospitalResidency, Pathology-Anatomic and Clinical, 1972 - 1976
University of the WitwatersrandClass of 1970
Certifications & Licensure
CA State Medical License 1977 - 2027
American Board of Pathology Anatomic Pathology & Clinical Pathology
Publications & Presentations
PubMed
- 79 citationsAssessment of Residual Cancer Burden and Event-Free Survival in Neoadjuvant Treatment for High-risk Breast Cancer: An Analysis of Data From the I-SPY2 Randomized Clini...W. Fraser Symmans, Christina Yau, Yunn Yi Chen, Ronald Balassanian, Molly Klein
JAMA Oncology. 2021-09-16 - 152 citationsAssociation of Event-Free and Distant Recurrence-Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Can...Douglas Yee, Angela DeMichele, Christina Yau, Claudine Isaacs, W. Fraser Symmans
JAMA Oncology. 2020-09-01 - 17 citationsFluorescent humanized anti-CEA antibody specifically labels metastatic pancreatic cancer in a patient-derived orthotopic xenograft (PDOX) mouse modelThinzar M. Lwin, Kentaro Miyake, Takashi Murakami, Jonathan C. DeLong, Siamak Amirfakhri
Oncotarget. 2018-12-18
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
